Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis. Fava J, Stephan E, Tansmore J, Sheikh S, et al. Pediatr Pulmonol 2026;61:e71749.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fava J, Stephan E, Tansmore J, Sheikh S, et al. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis. Pediatr Pulmonol 2026;61:e71749.
PMID: 42517727